Xingang Cui

Dr. Xingang Cui


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
YHYi Huang
Yi Huang
XPXiu-Wu Pan
Xiu-Wu Pan
LLLin Li
Lin Li
LCLu Chen
Lu Chen
XLXi Liu
Xi Liu
XCXingang Cui
Xingang Cui
Overexpression of USP39 predicts poor prognosis and promotes tumorigenesis of prostate cancer via promoting EGFR mRNA maturation and transcription elongation

27 November 2015 in BMC Urology
Verified
Journal Article
Open access
PDF file
YHYi Huang
Yi Huang
XPXiuwu Pan
Xiuwu Pan
QZQiwei Zhou
Qiwei Zhou
HHHai Huang
Hai Huang
LLLin Li
Lin Li
XCXingang Cui
Xingang Cui
Health-related quality-of-life (HRQoL) is an important consideration after radical cystectomy (RC). Lack of effective ways to assess HRQoL after RC and unawareness of disease-specific problems related to ileal conduit (IC) and orthotopic ileal neobladder (OIN) are serious problems. The present study was to evaluate and compare morbidity and HRQoL between IC and OIN after RC, and examine their unmet needs in the two groups. A retrospective analysis was made of 294 patients treated with RC in our hospital between 2007 and 2013. Matched pair analysis was used to determine the patients of IC and OIN groups. Patient HRQoL between IC and OIN groups was assessed using the bladder-specific bladder cancer index (BCI) and European Organization for Research and Treatment of Cancer Body Image scale (BIS) questionnaires. Unmet information of patients undergoing these two urinary diversions was recorded through individual interviews. Of the 117 included patients, 39 patients were treated with OIN and the other 78 matched patients with IC as controls for matched pair analysis. There was no significant difference in baseline characteristics between the two groups. OIN patients showed significantly better BIS scores in terms of HRQoL outcomes after RC at a short-term (1 year) follow-up level between the two groups. Interestingly, urinary bother (UB) and urinary function (UF) were poor in OIN patients at the one-year follow-up level, but there was no significant difference in UB between the two groups at the long term follow-up level. Unmet needs analysis showed that OIN patients had a more positive attitude towards treatment and participated in physical and social activities more positively, although they may have more urine leakage problems. The mean BIS score in OIN group patients was significantly better than that in IC group patients at the one-year follow-up level, but there was no significant difference at the long-term follow-up level. Due attention should be paid to some particular unmet needs in individual patients in managing the two UD modalities.

17 January 2016 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
JRJizhong Ren
Jizhong Ren
XPXiuwu Pan
Xiuwu Pan
LLLin Li
Lin Li
YHYi Huang
Yi Huang
HHHai Huang
Hai Huang
DXDanfeng Xu
Danfeng Xu

21 January 2026 in Oncology Reports
Verified
Journal Article
Open access
PDF file
XPXiu-Wu Pan
Xiu-Wu Pan
LLLin Li
Lin Li
YHYi Huang
Yi Huang
HHHai Huang
Hai Huang
DXDan-Feng Xu
Dan-Feng Xu
XCXingang Cui
Xingang Cui
Following the publication of the above article, the authors have contacted the Editorial Office to explain that they had noticed that, in Fig. 4 on p. 339, the same western blot data for the ATG5 protein had inadvertently been included for the T24 and the BT5637 cell lines for the 72 h experiments (the lower panels of blots). However, the authors had retained their original data, and were able to identify how this error occurred. The revised version of Fig. 4, now showing the correct data for the ATG5 protein for the 72 h experiment with the BT5637 cell line, is shown on the next page. Note that this error did not affect the overall results and conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for granting them the opportunity to publish this corrigendum, and all the authors agree with its publication; furthermore, they apologize to the readership of the journal for any inconvenience caused. [Oncology Reports 35: 334‑342, 2016; DOI: 10.3892/or.2015.4335]